Govt's target to vaccine 1 billion people in 2021 'not possible': ICMR

Experts from the ICMR-National Institute of Malaria Research and the Indian Council of Medical Research, on Wednesday, slammed the government for poor planning of the home-grown vaccine production and deployment, as a result of which "India doesn't have enough vaccines to go around".

While there are plans to significantly ramp up production of the Covaxin and Covishield vaccines, the target to vaccinate around one billion people may still not be reached this year, the experts said in a commentary published in the online journal BMJ Global Health.

Only around 3 per cent of the population has been inoculated till now.

The experts urged the government to expedite the approval of foreign vaccines already deployed elsewhere around the globe.

"As any protection conferred by Covid-19 vaccine is expected to take at least two weeks after both doses, and with large demands, India will require many more sources of vaccines in the coming days and weeks to stem the current uptick in infections," it said.

Further, to expand coverage, the government has allowed private hospitals to vaccinate, which charge anything from $3 to $15 (roughly Rs 220 to Rs 1,098), meaning very few people can afford it.

They urged the government to make vaccines against Coronavirus free for everyone in India, which will not only boost uptake but also curb the death toll from the infection.

On differential pricing of vaccines between Centre and states, the experts said it "is likely to be detrimental to public health at this time of grave crisis in India", creating inequitable distribution and potentially sparking public mistrust.

"For India to stem Covid-19, the nation cannot allow any differential approach for its residents."

The government-mandated pre-registration via a mobile app to create a vaccination records infrastructure for adults is also not feasible as only around a third of people in rural areas have an internet connection, the experts said.

Instead, a simple vaccination card may be a better option, they suggest.

Moreover, "the funding pledged by the government is far from adequate," the experts lamented, saying "this will be concerning in scenarios where a 3rd booster shot is required. Hence, India needs a corpus of funds for the above that covers all future eventualities of vaccine deployment," it said.

"India may need to reset its vaccine strategies, enhance the competence level of pandemic management and spur the bureaucratic machinery so that vaccine equity can be achieved in a very short span of time," it noted.

--IANS

rvt/in

 


(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel